BackBioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Other Current Assets

Latest other current assets for BIOSU: $190.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$194.00
99.95% YoYΔ $-420651.00 vs prior year quarter

Peer average / median

Loading

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Other Current Assets History

Loading

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) vs. peers: Other Current Assets Comparison

Loading

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War) (BIOSU) FAQ

The latest other current assets for BIOSU is $190 as of June 2023. That compares with $420K in the prior-year period — down 100.0% year over year. Investors often review this figure alongside BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOSU's other current assets moved from $420K to $190 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioPlus Acquisition - Units (1 Ord Share Class A & 1/2 War)'s operating scale or balance-sheet position.

A other current assets figure of $190 for BIOSU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BIOSU's other current assets ($190), review year-over-year change from $420K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.